Skip to content
Review

RNA cytosine modifications regulates musculoskeletal disorders

Jul 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 53 references
Medicine

TL;DR

This review systematically addresses the molecular basis and current knowledge on the mechanisms underlying RCMs in a variety of MSDs, along with translational strategies targeting these epitranscriptomic pathways.

View source

Similar papers

Review Open access Aug 2026

Epitranscriptomic Regulation of Bone Metabolism: Emerging Roles of N6‐Methyladenosine (m6A) Modification in Skeletal Homeostasis

The basic concepts of m6A modification are summarized and its emerging roles in the regulation of bone metabolism are discussed, with particular focus on osteoblasts, osteoclasts, osteocytes, and bone marrow mesenchymal stem cells.

S. Kokabu, Yuan Quan · 0 citations
Review Open access Oct 2026

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities

N⁴-acetylcytidine (ac⁴C) is an evolutionarily conserved RNA modification that was initially identified in transfer RNA (tRNA) and ribosomal RNA (rRNA). Increasing evidence has subsequently expanded its functional landscape to messenger RNA (mRNA) and multiple classes of non-coding RNAs (ncRNAs). As the best-characteriz...

Xiao-Yan He, Kang Du, Chao-Fu Yue et al. · 0 citations
Review Open access Sep 2026

The role and clinical impact of aberrant m6A RNA modification in cancer

This review systematically dissects how dysregulated m6A methylation fuels malignant transformation and progression by reinforcing core oncogenic hallmarks, sustained proliferation, metastasis, metabolic rewiring, and resistance to programmed cell death.

Sheng-Jie Tang, Rangping Xie, Jiang Fu et al. · 0 citations
Review Open access Sep 2026

The m6A methyltransferase METTL3 in intervertebral disc degeneration: from molecular mechanisms to therapeutic potential

Intervertebral disc degeneration (IDD) is the fundamental pathological process underlying low back pain, a major cause leading to disability worldwide. As the most prevalent methylation modification in eukaryotic RNA molecules, N6-methyladenosine (m 6 A) is involved in various diseases and cellular processes by reg...

Yi-Chun Zhou, X. Xiang, Geng Li et al. · 0 citations
Review Open access Sep 2026

RNA m6A modification-regulated ferroptosis in cancer: mechanism and therapeutic potential

Empirical evidence elucidating how m6A regulators remodel cystine import, GPX4-dependent antioxidant defense, FSP1 signaling, lipid metabolism, iron handling, autophagy and tumor-microenvironmental communication is synthesized.

Qing-Miao Shi, Yang-Ni Li, Chao Guan · 0 citations
Review Sep 2026

RNA modifications and metabolism in cancer: mechanisms, cross-talk and therapeutic implications.

RNA modifications, particularly in the realm of epitranscriptomics, have emerged as crucial regulatory factors in cancer progression, influencing cancer cell behavior by reprogramming metabolic pathways. These modifications, such as N⁶-methyladenosine (m⁶A), 5-methylcytosine (m⁵C), N¹-methyladenosine (m¹A), N⁷-methylgu...

Xin Luo, Xin-Zhao Zuo, Jing-Ke He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.